• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Agar dilution minimum inhibitory concentrations under-represent oritavancin in vitro activity against staphylococci and enterococci.

作者信息

Arhin Francis F, Moeck Gregory

机构信息

The Medicines Company, 7170 Frederick Banting, St. Laurent, Quebec H4S 2A1, Canada.

The Medicines Company, 7170 Frederick Banting, St. Laurent, Quebec H4S 2A1, Canada.

出版信息

J Glob Antimicrob Resist. 2017 Jun;9:85-86. doi: 10.1016/j.jgar.2017.03.002. Epub 2017 Apr 25.

DOI:10.1016/j.jgar.2017.03.002
PMID:28455075
Abstract
摘要

相似文献

1
Agar dilution minimum inhibitory concentrations under-represent oritavancin in vitro activity against staphylococci and enterococci.琼脂稀释法测定的最低抑菌浓度低估了奥利万星对葡萄球菌和肠球菌的体外活性。
J Glob Antimicrob Resist. 2017 Jun;9:85-86. doi: 10.1016/j.jgar.2017.03.002. Epub 2017 Apr 25.
2
In vitro activity of oritavancin against planktonic and biofilm states of vancomycin-susceptible and vancomycin-resistant enterococci.奥利万星对万古霉素敏感和耐药肠球菌浮游菌态及生物被膜态的体外活性。
Diagn Microbiol Infect Dis. 2018 Aug;91(4):348-350. doi: 10.1016/j.diagmicrobio.2018.03.008. Epub 2018 Mar 16.
3
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci.研究性糖肽类抗生素LY333328对肠球菌和葡萄球菌的体外活性。
Antimicrob Agents Chemother. 1996 Oct;40(10):2416-9. doi: 10.1128/AAC.40.10.2416.
4
In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.2011-2014 年欧洲和北美的临床感染分离的葡萄球菌、链球菌和肠球菌对奥利万星及其他比较药物的体外活性研究。
Int J Antimicrob Agents. 2015 Dec;46(6):674-81. doi: 10.1016/j.ijantimicag.2015.08.014. Epub 2015 Oct 20.
5
Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.2011 年西欧国家分离的耐甲氧西林金黄色葡萄球菌、耐万古霉素肠球菌和β-溶血性链球菌的奥塔万古霉素活性。
J Antimicrob Chemother. 2013 Jan;68(1):164-7. doi: 10.1093/jac/dks344. Epub 2012 Aug 30.
6
In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides.新型糖肽类抗生素替加环素（GAR-936）对万古霉素耐药肠球菌及对糖肽类敏感性降低的葡萄球菌的体外活性。
J Antimicrob Chemother. 2003 Jul;52(1):138-9. doi: 10.1093/jac/dkg289. Epub 2003 Jun 12.
7
Prevalence of macrolide-lincosamide resistance and multidrug resistance phenotypes in streptococcal isolates causing infections in European hospitals: Evaluation of the in vitro activity of oritavancin and comparator agents.导致欧洲医院感染的链球菌分离株中大环内酯-林可酰胺类耐药和多种药物耐药表型的流行情况：评估奥利万星和比较剂的体外活性。
J Glob Antimicrob Resist. 2017 Mar;8:28-32. doi: 10.1016/j.jgar.2016.08.013. Epub 2016 Nov 2.
8
Impact of human serum albumin on oritavancin in vitro activity against enterococci.人血清白蛋白对奥利万星体外抗肠球菌活性的影响。
Antimicrob Agents Chemother. 2009 Jun;53(6):2687-9. doi: 10.1128/AAC.00197-09. Epub 2009 Apr 6.
9
Activity of vancomycin, linezolid, and daptomycin against staphylococci and enterococci isolated in 5 Greek hospitals during a 5-year period (2008-2012).万古霉素、利奈唑胺和达托霉素对希腊5家医院在5年期间（2008 - 2012年）分离出的葡萄球菌和肠球菌的活性。
Diagn Microbiol Infect Dis. 2015 Dec;83(4):386-8. doi: 10.1016/j.diagmicrobio.2015.08.002. Epub 2015 Aug 5.
10
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.达托霉素与利奈唑胺及万古霉素针对引起复杂性尿路感染的革兰氏阳性尿路病原体的体外活性，以及氨苄西林针对肠球菌的体外活性。
Chemotherapy. 2005 May;51(2-3):64-9. doi: 10.1159/000085611. Epub 2005 May 4.

引用本文的文献

1
New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides.新型抗菌药物：长作用糖肽类。
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0261420. doi: 10.1128/aac.02614-20. Epub 2022 Apr 27.
2
Evaluation of Non-Tissue Culture- versus Tissue Culture-Treated Microplates for Oritavancin Susceptibility Testing.用于奥利万星药敏试验的非组织培养处理与组织培养处理微孔板的评估
J Clin Microbiol. 2018 Mar 26;56(4). doi: 10.1128/JCM.02001-17. Print 2018 Apr.